A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT01455142

Femme et Homme

  • | Pays :
  • Austria
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This trial is conducted in Europe. The aim of the trial is to test for bioequivalence between two formulations of insulin degludec/insulin aspart (IDegAsp) to see if the efficacy and safety obtained with formulation 1 can be assumed identical for formulation 2.


Critère d'inclusion

  • diabetes ,Diabetes Mellitus, Type 1

Liens